Abstract
MicroRNAs (miRNAs) comprise an important class of small single-stranded non-coding RNAs that regulate several important biological processes, including cell differentiation, growth, and apoptosis. The dysregulations of miRNAs are usually correlated with several diseases because of their regulatory functions in organisms. Over the past few years, miRNAs are often observed to be aberrantly expressed in cancers, indicating their potential correlations with cancer pathogenesis. Recently, evidence has increased to prove this assumption. Further investigations show that miRNAs are involved extensively in various cancer cell processes on the molecular level, including promotions of cancer cell development. Considering the important functions of miRNAs in cancer development, investigating the relationship between miRNAs and cancers can lead to a better understanding of the latter. Therefore, this review summarizes recent developments from related studies, particularly focusing on the functions of miRNAs and their potential applications as therapeutic strategies for cancers.
Keywords: Cancer, microRNAs, oncogenes, prognosis, tumor suppressors.
Current Bioinformatics
Title:A Discussion of MicroRNAs in Cancers
Volume: 9 Issue: 5
Author(s): Shi Hua, Wu Yun, Zeng Zhiqiang and Quan Zou
Affiliation:
Keywords: Cancer, microRNAs, oncogenes, prognosis, tumor suppressors.
Abstract: MicroRNAs (miRNAs) comprise an important class of small single-stranded non-coding RNAs that regulate several important biological processes, including cell differentiation, growth, and apoptosis. The dysregulations of miRNAs are usually correlated with several diseases because of their regulatory functions in organisms. Over the past few years, miRNAs are often observed to be aberrantly expressed in cancers, indicating their potential correlations with cancer pathogenesis. Recently, evidence has increased to prove this assumption. Further investigations show that miRNAs are involved extensively in various cancer cell processes on the molecular level, including promotions of cancer cell development. Considering the important functions of miRNAs in cancer development, investigating the relationship between miRNAs and cancers can lead to a better understanding of the latter. Therefore, this review summarizes recent developments from related studies, particularly focusing on the functions of miRNAs and their potential applications as therapeutic strategies for cancers.
Export Options
About this article
Cite this article as:
Hua Shi, Yun Wu, Zhiqiang Zeng and Zou Quan, A Discussion of MicroRNAs in Cancers, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140804221135
DOI https://dx.doi.org/10.2174/1574893609666140804221135 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Trp/Met/Phe Hot Spots in Protein-Protein Interactions: Potential Targets in Drug Design
Current Topics in Medicinal Chemistry Composite Lymphomas: A Challenging Entity
Current Cancer Therapy Reviews Novel 1, 2, 3-Triazole-Linked Norcantharidin Analogues: Synthesis and Evaluation of Growth Inhibition in a Panel of Selected Tumor-Cell Lines
Letters in Drug Design & Discovery Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Synthesis and Anticancer Activity of Some 1H-inden-1-one Substituted (Heteroaryl)Acetamide Derivatives
Letters in Drug Design & Discovery AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology New Insights Into Biology of Chronic Myeloid Leukemia: Implications in Therapy
Current Cancer Drug Targets Infrared-Spectroscopy: A Non-Invasive Tool for Medical Diagnostics and Drug Analysis
Current Medicinal Chemistry Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The “Tilted Peptide Theory” Links Membrane Insertion Properties and Fusogenicity of Viral Fusion Peptides
Protein & Peptide Letters Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
CNS & Neurological Disorders - Drug Targets Emerging Breast Cancer Biomarkers
Current Cancer Therapy Reviews Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry Innovative Drug Delivery Systems for the Administration of Natural Compounds
Current Bioactive Compounds HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy
Current Gene Therapy Advances in Tumor Targeted Liposomes
Current Molecular Medicine HTLV-1 Associated Neurological Disorders
Current Topics in Medicinal Chemistry Increase in the Non-HIV-Related Deaths Among Aids Cases in the HAART Era
Current HIV Research Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy Intracellular ROS Generation Mediates Maleimide-induced Cytotoxicity in Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry